Brian Jacoby

Brian Jacoby has extensive work experience in the medical affairs field. Brian is currently working as the VP Medical Affairs at Galecto, Inc. Prior to this, they served as a Senior Medical Affairs Consultant at MedConsult from 2020 to 2022. Before that, they held the position of Vice President and Head of Global Medical Affairs at Orphazyme A/S from 2019 to 2020. Brian also worked as a Senior Medical Affairs Consultant at MedConsult from 2018 to 2019.

Brian's earlier experience includes roles at LEO Pharma, where they served as the Sr. Director and Head of Global Medical Affairs from 2012 to 2018. Brian was also the Medical Director and Head of Corporate Medical Affairs at LEO Pharma from 2010 to 2012.

Prior to LEO Pharma, Brian worked at UCB as a Medical Director from 2008 to 2010. Brian was responsible for Medical Affairs, Regulatory Affairs, Pharmacovigilance, and Quality Management System (QMS) at the Nordic affiliate. Brian successfully developed and implemented the Medical Affairs strategy for various product launches.

Before UCB, Brian held the position of Medical Director at Roche a/s from 2002 to 2008. Here, they designed and established the separate Medical Affairs division in the Danish affiliate. Brian oversaw several functions including Medical Affairs, Regulatory Affairs, Pharmacovigilance, and QMS, and played a key role in expanding the department.

Brian's career began at Novo Nordisk in 2000, where they worked as a Safety Adviser. Brian was responsible for safety monitoring in high-risk clinical studies and played a pivotal role in establishing Novo Nordisk Data and Safety Monitoring Boards.

Overall, Brian Jacoby's work experience demonstrates their expertise in medical affairs, strategic planning, global medical affairs strategy implementation, and stakeholder engagement.

Brian Jacoby earned a Doctor of Medicine (MD) degree from Københavns Universitet - University of Copenhagen in 1996. Brian later pursued a Master of Business Administration (MBA) degree from Henley Business School, which was completed in 2017.